StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Amgen Inc.
NasdaqGS:AMGN
Sector
Location
Market Cap
USD 158.49 B
Share Price
USD 294.76
Avg Daily Volume
2,944,316
Change (1 day)
-1.17%
Change (1 year)
-10.94%
Change (YTD)
13.09%
Amgen Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2025: 92.94%
Amgen Inc. Return on Equity (ROE) is 92.94% for the Trailing 12 Months (TTM) ending March 31, 2025, a 58.62% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.
-
Amgen Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2024 was 58.59%, a -72.10% change year over year.
-
Amgen Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2023 was 209.99%, a 120.88% change year over year.
-
Amgen Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2022 was 95.07%, a 35.39% change year over year.
-
Amgen Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2021 was 70.22%, a -6.50% change year over year.
Competitors
Eli Lilly and Company
USD 771.71
LLY
+10.21
1.34%
AbbVie Inc.
USD 189.26
ABBV
-2.14
-1.12%
Roche Holding AG
USD 340.88
RO.SW
+2.44
0.72%
AstraZeneca PLC
USD 138.02
AZN.L
-0.31
-0.22%
Merck & Co., Inc.
USD 79.96
MRK
-1.56
-1.91%
Pfizer Inc.
USD 24.47
PFE
-0.11
-0.45%
Gilead Sciences, Inc.
USD 108.22
GILD
-0.58
-0.53%
Sanofi
USD 96.63
SAN.PA
-0.24
-0.24%
Bristol-Myers Squibb Company
USD 47.36
BMY
-0.70
-1.46%
Chugai Pharmaceutical Co., Ltd.
USD 47.05
4519.T
+0.49
1.05%
GSK plc
USD 18.07
GSK.L
-0.88
-4.65%
Regeneron Pharmaceuticals, Inc.
USD 542.52
REGN
-7.48
-1.36%
Cencora, Inc.
USD 292.87
COR
-1.51
-0.51%
Jiangsu Hengrui Medicine Co., Ltd.
USD 8.18
600276.SS
+0.14
1.80%
Takeda Pharmaceutical Company Limited
USD 29.16
4502.T
-0.53
-1.77%
Haleon plc
USD 4.81
HLN.L
-0.00
-0.08%
Daiichi Sankyo Company, Limited
USD 24.17
4568.T
+0.03
0.11%
Ucb S.A.
USD 203.26
UCB.BR
+1.51
0.75%
BeOne Medicines Ltd.
USD 294.55
ONC
+4.20
1.45%
Hansoh Pharmaceutical Group Company Limited
USD 4.59
3692.HK
+0.20
4.51%
Key Data
| Date | Return on Equity (ROE) | Return on Assets (ROA) | Revenue Per Share | Free Cash Flow Per Share |
|---|
Competitors
Eli Lilly and Company
USD 771.71
LLY
+10.21
1.34%
AbbVie Inc.
USD 189.26
ABBV
-2.14
-1.12%
Roche Holding AG
USD 340.88
RO.SW
+2.44
0.72%
AstraZeneca PLC
USD 138.02
AZN.L
-0.31
-0.22%
Merck & Co., Inc.
USD 79.96
MRK
-1.56
-1.91%
Pfizer Inc.
USD 24.47
PFE
-0.11
-0.45%
Gilead Sciences, Inc.
USD 108.22
GILD
-0.58
-0.53%
Sanofi
USD 96.63
SAN.PA
-0.24
-0.24%
Bristol-Myers Squibb Company
USD 47.36
BMY
-0.70
-1.46%
Chugai Pharmaceutical Co., Ltd.
USD 47.05
4519.T
+0.49
1.05%
GSK plc
USD 18.07
GSK.L
-0.88
-4.65%
Regeneron Pharmaceuticals, Inc.
USD 542.52
REGN
-7.48
-1.36%
Cencora, Inc.
USD 292.87
COR
-1.51
-0.51%
Jiangsu Hengrui Medicine Co., Ltd.
USD 8.18
600276.SS
+0.14
1.80%
Takeda Pharmaceutical Company Limited
USD 29.16
4502.T
-0.53
-1.77%
Haleon plc
USD 4.81
HLN.L
-0.00
-0.08%
Daiichi Sankyo Company, Limited
USD 24.17
4568.T
+0.03
0.11%
Ucb S.A.
USD 203.26
UCB.BR
+1.51
0.75%
BeOne Medicines Ltd.
USD 294.55
ONC
+4.20
1.45%
Hansoh Pharmaceutical Group Company Limited
USD 4.59
3692.HK
+0.20
4.51%